Legend BiotechLEGN

那斯達克 · USD
18.97
+1.22
(+6.87%)
收盤 03/07 04:59 (UTC+8)
盤後 
18.92 
18.92 
(-0.26%)
03/07 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.73
  • 0.96
  • 0.79
  • 0.94
  • 1.87
  • 1.60
  • 1.87
  • 1.95
  • 2.55
  • 2.72
icon
  • 101.81
  • 30.93
  • -17.24
  • 18.28
  • 98.45
  • -14.11
  • 16.43
  • 4.57
  • 30.76
  • 6.77
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
272,330
255,058
195,053
186,522
160,205
186,523
93,991
79,464
96,013
73,330
營業成本
115,30697,99171,34473,92255,46950,45154,73932,45043,47932,672
營業毛利
157,024
157,067
123,709
112,600
104,736
136,072
39,252
47,014
52,534
40,658
營業費用
200,476178,948174,356186,995175,092178,042157,116166,864144,881143,621
研發費用
113,14898,302101,924104,43295,522112,626100,964105,68395,85595,791
推銷及管理費用
87,32880,64672,43283,12679,57065,41656,15262,38449,20249,182
非經常性項目費用
----------
其他營業費用
----563-306-420-616-1,203-176-
營業利益
-43,452
-21,881
-50,647
-74,395
-70,356
-41,970
-117,864
-119,850
-92,347
-102,963
其他收入及費用
----------
利息費用
5,6365,2225,0615,1525,5045,4845,4755,8205,6765,185
稅前純益
-39,073
-124,798
-99,130
40,511
-120,886
-17,970
-59,788
-146,812
-62,495
-198,838
所得稅
6165821,78614,2274,4352265-1,994-288290
稅後純益
-39,689
-125,380
-100,916
26,284
-125,321
-18,196
-59,793
-144,818
-62,207
-199,128
基本每股稅後盈餘(元)
-0.22-0.68-0.540.14-0.68-0.10-0.32-0.80--1.14
稀釋每股稅後盈餘(元)
-0.22-0.68-0.540.14-0.68-0.10-0.32-0.80--1.14
基本平均股數(千股)
184636.00184135.00183762.00183324.00183281.00182602.00182005.00181827.00-175531.00
稀釋平均股數(千股)
184636.00184135.00183762.00201403.00183281.00182602.00182005.00181827.00-175531.00
還原基本每股稅後盈餘(元)
-0.22-0.68-0.540.14-0.68-0.10-0.32-0.80--1.14
還原稀釋每股稅後盈餘(元)
-0.22-0.68-0.540.14-0.68-0.10-0.32-0.80--1.14
還原基本平均股數(千股)
184,636184,135183,762183,324183,281182,602182,005181,827-175,531
還原稀釋平均股數(千股)
184,636184,135183,762201,403183,281182,602182,005181,827-175,531
EBITDA(千元)
-27,558-113,722-88,87052,459-111,475-7,117-48,591-135,641-51,648-193,653

大家都在看

HOT